ENeura

10/09/2025

When explaining how single-pulse Transcranial Magnetic Stimulation (sTMS) works, we often use the picture of a summer thunderstorm.

𝗠𝗶𝗴𝗿𝗮𝗶𝗻𝗲 𝗶𝘀 𝗹𝗶𝗸𝗲 𝗮𝗻 𝗲𝗹𝗲𝗰𝘁𝗿𝗶𝗰𝗮𝗹 𝘀𝘁𝗼𝗿𝗺 𝗶𝗻 𝘁𝗵𝗲 𝗯𝗿𝗮𝗶𝗻—𝗱𝗮𝗿𝗸 𝘀𝗸𝗶𝗲𝘀 𝗯𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗾𝘂𝗶𝗰𝗸𝗹𝘆, 𝗯𝘂𝗿𝘀𝘁𝘀 𝗼𝗳 𝗹𝗶𝗴𝗵𝘁𝗻𝗶𝗻𝗴, 𝗮𝗻𝗱 𝘀𝘂𝗱𝗱𝗲𝗻 𝗱𝗶𝘀𝗿𝘂𝗽𝘁𝗶𝗼𝗻.

Patients don’t always want the deep science; they just want to understand how and why it works. The storm analogy helps to make it clear: sTMS delivers brief electromagnetic pulses that help calm that storm before it takes over.

It’s a simple way to describe something very complex. For patients, that picture can make all the difference in understanding their treatment.

☀️ Clearer skies are a real possibility for so many. The time for awareness is now.


🔗https://eneura.com/

10/08/2025

Incredible

"Could targeted magnetic stimulation offer more than symptom relief—perhaps even circuit repair—in dementia?"

Scientific Horizons is your gateway to expert-driven insights, uncovering the latest breakthroughs in healthcare, biotech and scientific research Reprogrammed Human Neurons Reveal How Aging Drives Brain Degeneration Anna Anoir Abbas - KDP-PhD student at HCEMM-SU Neurobiology and Neurodegenerative Di

10/07/2025

The OVERCOME (US) study shows that over 1 in 5 patients (21.5%) are currently using opioids to manage migraine symptoms. This is despite recommendations against opioid use due to the risks: increased headache days, greater disability, medication overuse, and reliance on emergency care.

This underscores why we need safe, effective alternatives. Single-pulse Transcranial Magnetic Stimulation (sTMS) provides that option. Unlike opioids, sTMS is:

✅ Non-addictive
✅ Patient-controlled
✅ Safe and well-tolerated
✅ Effective for both acute and preventive migraine care

Veterans and civilian patients remind us daily that neuromodulation can improve lives without the risks of opioids. It’s time to accelerate awareness and access to these solutions that treat the underlying neurological dysfunction, not just mask the pain.

Source: https://lnkd.in/ebQkS2WS

10/06/2025

We can read every book on leadership and business… but the lessons we've learned on LinkedIn are highly underrated.

As veterans know, commanders are trained to shape the battlefield—adapt, learn, and position assets for success. Leadership in the civilian world is no different.

𝗧𝗵𝗶𝘀 𝗰𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗶𝗻𝘃𝗮𝗹𝘂𝗮𝗯𝗹𝗲. The shared insights, challenges, and perspectives, particularly in MedTech, have pushed us to think differently, work smarter, and improve.

Promotion is one thing. Growth is another. And since we genuinely look forward to Mondays at work, we must be in the right place.

(h/t to Lindsay Hartland for his post on Monday that reminded us of just how important that feeling is.)

10/05/2025

What an incredible week at the Military Influencer Conference. Thank you all!

The future is bright. There was no shortage of veteran advocates who already know the impact Transcranial Magnetic Stimulation (TMS) has had in behavioral health. The excitement around a patient-controlled, portable TMS device for a neurological disorder like migraine was palpable.

𝗢𝘃𝗲𝗿 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝗳𝗲𝘄 𝗱𝗮𝘆𝘀, 𝘄𝗲𝗲𝗸𝘀, 𝗮𝗻𝗱 𝗺𝗼𝗻𝘁𝗵𝘀, 𝘃𝗲𝘁𝗲𝗿𝗮𝗻𝘀 𝗮𝗿𝗲 𝗴𝗼𝗶𝗻𝗴 𝘁𝗼 𝗯𝗲 𝗲𝗻𝗴𝗮𝗴𝗶𝗻𝗴 𝗶𝗻 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻𝘀 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲𝗶𝗿 𝗽𝗿𝗼𝘃𝗶𝗱𝗲𝗿𝘀. Those providers and thought-leaders who have been at the forefront of this disruptive technology will be highly sought after for their feedback and opinions on the possibilities with sTMS therapy. And it’s not just here in the U.S.—𝗲𝘃𝗲𝗻 𝗼𝘂𝗿 𝗡𝗔𝗧𝗢 𝗮𝗹𝗹𝗶𝗲𝘀 𝘄𝗶𝗹𝗹 𝗯𝗲𝗻𝗲𝗳𝗶𝘁 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗺𝗼𝗺𝗲𝗻𝘁𝘂𝗺 𝘁𝗵𝗮𝘁 𝘀𝘁𝗮𝗿𝘁𝗲𝗱 𝘁𝗵𝗶𝘀 𝘄𝗲𝗲𝗸.

The ball is rolling, and with numerous speaking engagements and presentations ahead, awareness and access will continue to expand. Not only for the veteran community, but for patients globally.

A special thanks to Jami Raishbrook for the invitation to attend and for her encouragement—it made all the difference.
We've never been more excited. Grateful for the friends and allies gained this week as we continue moving forward together. 𝗔𝗟𝗟 𝗧𝗛𝗘 𝗪𝗔𝗬!

🔗https://eneura.com/

10/01/2025

𝗩𝗲𝘁𝗲𝗿𝗮𝗻𝘀 𝗦𝗵𝗮𝗿𝗲 𝗪𝗵𝗮𝘁 𝘁𝗵𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗖𝗼𝗻𝗳𝗶𝗿𝗺𝘀: 𝗠𝗶𝗴𝗿𝗮𝗶𝗻𝗲 𝗛𝘂𝗿𝘁𝘀 𝗠𝗼𝗿𝗲 𝗧𝗵𝗮𝗻 𝘁𝗵𝗲 𝗛𝗲𝗮𝗱

A review published (Pathophysiology of migraine-related cognitive dysfunction, Cephalalgia, 2025) highlights how migraine affects the brain well beyond pain. Patients often experience difficulties with attention, memory, processing speed, and overall cognitive performance not only during attacks but even between them. These deficits can impact quality of life, work, and daily function in ways that are often overlooked.

In our work with veterans using single-pulse transcranial magnetic stimulation (sTMS), our clinical team frequently hears feedback that treatment doesn’t just reduce migraine pain—it also helps patients feel clearer, sharper, and more focused. This paper reinforces what patients are telling us: 𝗺𝗶𝗴𝗿𝗮𝗶𝗻𝗲 𝗵𝗮𝘀 𝗮 𝗽𝗿𝗼𝗳𝗼𝘂𝗻𝗱 𝗻𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗶𝗺𝗽𝗮𝗰𝘁 𝘁𝗵𝗮𝘁 𝗰𝗮𝗻 𝗯𝗲 𝗮𝗱𝗱𝗿𝗲𝘀𝘀𝗲𝗱.

Veterans and civilians alike deserve therapies that don’t just manage pain but help restore quality of life. SAVI Dual represents one such option, offering a safe, non-medication approach that targets migraine at its source.


Source:
https://lnkd.in/e9VX-rFq

10/01/2025

✅ Fewer migraines
✅ Less medication
✅ Better days

That’s the power of sTMS.
Learn more at: https://eneura.com/

09/30/2025

Yes, we know we sound like a broken record when I highlight 𝗰𝗼𝗿𝘁𝗶𝗰𝗮𝗹 𝘀𝗽𝗿𝗲𝗮𝗱𝗶𝗻𝗴 𝗱𝗲𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 (𝗖𝗦𝗗), but it remains one of the central drivers of migraine pathogenesis and represents a key target early in an acute attack.

A recent preclinical study (Kaur et al., 2025) demonstrated that when CSD is triggered in animal models, it produces light sensitivity (photophobia) and heightened facial pain sensitivity (allodynia). Both were more pronounced and longer lasting in females, aligning with the real-world observation that women experience more frequent and severe migraine attacks.

This matters because it underscores why targeting CSD directly can be so powerful for patients. 𝗦𝗶𝗻𝗴𝗹𝗲-𝗽𝘂𝗹𝘀𝗲 𝗧𝗿𝗮𝗻𝘀𝗰𝗿𝗮𝗻𝗶𝗮𝗹 𝗠𝗮𝗴𝗻𝗲𝘁𝗶𝗰 𝗦𝘁𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 (𝘀𝗧𝗠𝗦) 𝘄𝗼𝗿𝗸𝘀 𝗯𝘆 𝗶𝗻𝘁𝗲𝗿𝗿𝘂𝗽𝘁𝗶𝗻𝗴 𝗖𝗦𝗗 𝗮𝘁 𝗶𝘁𝘀 𝘀𝗼𝘂𝗿𝗰𝗲. The therapy is non-invasive, drug-free, and avoids the risks of adverse events associated with medications.

For patients who cannot tolerate medications, or who are looking for options that address the cause rather than just the symptoms, sTMS offers a therapeutic pathway.


Source:
https://lnkd.in/eAddAFtp

09/29/2025

Stop pain before it starts!🧠✨

Use sTMS daily to reduce migraine frequency and take back control.
🔗https://eneura.com/

09/27/2025

Hear how eNeura made a real difference!💙✨🧠

https://eneura.com/

09/26/2025

The cat’s out of the bag 🎉

Excited to share that eNeura and our single-pulse Transcranial Magnetic Stimulation (sTMS) technology were at the Military Influencer Conference 2025.

We were encouraged to attend based on feedback from early adopters and veteran patients who have seen firsthand the impact of central neuromodulation in migraine care. Their voices matter and they’re helping open doors for broader awareness and access.

𝗧𝗵𝗲𝗿𝗲 𝗶𝘀 𝘀𝘁𝗶𝗹𝗹 𝘄𝗼𝗿𝗸 𝘁𝗼 𝗱𝗼. 𝗞𝗲𝗲𝗽 𝗺𝗼𝘃𝗶𝗻𝗴 𝗳𝗼𝗿𝘄𝗮𝗿𝗱.

09/22/2025

💰 𝗠𝗶𝗴𝗿𝗮𝗶𝗻𝗲: 𝗧𝗵𝗲 𝗛𝗶𝗱𝗱𝗲𝗻 𝗥𝗲𝘃𝗲𝗻𝘂𝗲 𝗞𝗶𝗹𝗹𝗲𝗿

Migraine is the second leading cause of disability worldwide, yet many business leaders don’t realize just how much it’s costing their bottom line. This referenced study of over 5,700 employees (in a healthcare system no less) found those who screened positive for migraine missed 0.66 workdays and had 3.77 days with productivity reduced by at least 50% in just a 3-month period—equating to about 𝟭𝟬.𝟭 𝗹𝗼𝘀𝘁 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝘃𝗲 𝗱𝗮𝘆𝘀 𝗽𝗲𝗿 𝘆𝗲𝗮𝗿 per employee with migraine.

Forward-thinking companies are recognizing that this loss adds up fast. Cost-effective migraine management—especially options like safe, effective 𝘀𝗶𝗻𝗴𝗹𝗲-𝗽𝘂𝗹𝘀𝗲 𝘁𝗿𝗮𝗻𝘀𝗰𝗿𝗮𝗻𝗶𝗮𝗹 𝗺𝗮𝗴𝗻𝗲𝘁𝗶𝗰 𝘀𝘁𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 (𝘀𝗧𝗠𝗦), can reduce migraine days, lower medication use, and restore productivity.

𝗘𝗺𝗽𝗹𝗼𝘆𝗲𝗲 𝗯𝗲𝗻𝗲𝗳𝗶𝘁 𝗽𝗹𝗮𝗻𝘀 𝘁𝗵𝗮𝘁 𝘁𝗮𝗸𝗲 𝘁𝗵𝗶𝘀 𝗿𝗼𝘂𝘁𝗲 𝗰𝗮𝗻 𝗽𝗿𝗼𝘁𝗲𝗰𝘁 𝗿𝗲𝘃𝗲𝗻𝘂𝗲.

👉 How many leaders are factoring migraine into ROI models? Or even aware of its massive toll on employee health and productivity? For most, the reality will come as a surprise. However, there are some who are leading the way.



https://lnkd.in/eTDSd9Xc

Migraine is common and disabling, and yet most migraine-related productivity loss is not readily detected by employers. This study is a survey offered to all 33,761 employees of a large healthcare sy...